PHILIPS'® MAGNESIA TABLETS USP
Natural health product licensed in Canada
- Licence holder
- Bayer Inc.
- NPN or DIN-HM
- 02150638
- Status
- Inactive licence
- Licence date
- 6 March 2008
- Revision date
- Not provided
- Form
- Comprimé, à croquer
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Dextrates, Stéarate de magnésium, Dioxyde de silicium, Maltodextrine, Huile de menthe poivrée, Saccharose, Amidon
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 2 years ; maximum: 5 years | minimum: 1 Comprimé ; maximum: 3 Comprimé | Not specified |
| Adultes | minimum: 12 years | minimum: 6 Comprimé ; maximum: 8 Comprimé | Not specified |
| Adultes | Not specified | minimum: 2 Comprimé ; maximum: 4 Comprimé | maximum: 4 Tous les jours |
| Enfants | minimum: 6 years ; maximum: 11 years | minimum: 3 Comprimé ; maximum: 6 Comprimé | Not specified |
Uses authorised in Canada
Antacid and laxative.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Do not use if seal under cap is broken or missing. Keep tightly closed. Consult a doctor before taking this product if you suffer from kidney disease, are on tetracycline, or have noticed a sudden change in bowel habits persisting for over 2 weeks. Not to be used when abdominal pain, nausea, fever or vomiting are present. Do not take within 2 hours of other medicines. Overuse or extended use may cause dependence for bowel function. If symptoms persist for more than 1 week, see a doctor. Rectal bleeding or failure to have a bowel movement after use may indicate a serious condition; discontinue use and consult a doctor. In case of accidental overdose, contact a poison control centre or your doctor immediately. Keep out of reach of children.
Source
Official Health Canada record, licence 02150638
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.